SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : FDA - Stocks close to approval: List them here

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Keith Anderson who wrote ()7/1/1996 10:10:00 PM
From: STEVEN OLIVEIRA   of 83
 
THERE ARE TWO THAT I'M AWARE OF. THE FIRST BEING
SEPRACOR(SEPR). THEY'VE DEVELOPED IN COLLABORATION
WITH HOECHST MARION A NEW, SAFER VERSION OF SELDANE, THE
ANTIHISTAMINE WHICH IS ONE OF MARION'S TOP SELLING
DRUGS. MARION FILED THE NDA JULY 31, 1995 AND IS
EXPECTING AN APPROVAL BEFORE THE END OF THIS
MONTH. NOTE ALSO, THAT AN FDA ADVISORY PANEL
HAD BEEN SCHEDULED TO MEET ON MAY 10, 1996, BUT
IT WAS CANCELLED IT SEEMS BECAUSE THERE WEREN'T ANY
SIGNIFICANT ISSUES TO DISCUSS. THIS WOULD BE
SEPRACOR'S FIRST APPROVED DRUG AND THEY ARE
EXPECTED TO RECEIVE AN 8% ROYALTY ON ALL PRESCRIPTION
SALES IN THE U.S. STARTING IN 1999.
THE SECOND IS NEOPROBE(NEOP), A COMPANY THAT HAS DEVELOPED A CANCER DIAGNOSTIC SYSTEM. THEY'RE EXPECTNG EUROPEAN APPROVAL FOR COLORECTAL CANCER BY THE END OF OCTOBER AND APPROVAL IN ASIA BY YEAREND. THIS WOULD BE THE FIRST APPROVAL FOR THEM ALSO.

THE INFORMATION STATED HERE IS MERELY AN OPINION FROM SOURCES BELIEVED TO BE RELIABLE.
THIS IS NOT A RECOMMENDATION OR SOLICITATION.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext